A Collaborative Approach to Drug Development
Posted 24th January 2012 in Articles, General | Register to comment
As Quintiles releases its latest New Health Report, Jeffrey Spaeder looks at the role of patients, payers and physicians in the clinical development process.
In order for new therapies to meet the needs of all the stakeholders, an increasing emphasis by the biopharmaceutical industry on early collaborations with…
Read the full articleHow pharma can help scale mHealth? The three things pharma companies need to do
Posted 23rd January 2012 in Articles, General | Register to comment
Vaibhav Gujral provides a walk through on how pharma companies can successfully penetrate the field of mobile health.
Despite the global boom in mobile phone penetration, particularly in the last five years, adoption of mHealth solutions at…
Read the full articleWhy is social media compliance important?
Posted 20th January 2012 in Articles, General | Register to comment
Darshan Kulkarni shares his views on the importance of remaining compliant within the FDA regulations when it comes to social media use.
The recent warning and untitled letters have demonstrated that the FDA is reviewing websites and social media to find instances of…
Read the full articleQR Codes – applications and innovations for pharma
Posted 19th January 2012 in Articles, General | Register to comment
Nick Plank demystifies the area of QR codes and shares how they can be of use in pharma.
QR what? Reading this in a recent email from a friend of mine who I have always thought to be super switched on to high-tech and is a…
Read the full articlePharma vs. physician: how data can relieve the headache (part 2)
Posted 18th January 2012 in Articles, General | Register to comment
Concluding its two-part article, Appature’s CTO discusses how you can make sense of your data.
In the healthcare industry, data is everywhere. From Web traffic on multiple brand websites and micro-sites, internal and purchased…
Read the full articleAre apps medical devices? Part one: what is the impact on pharma as the first app is registered as medical device with the MHRA?
Posted 17th January 2012 in Articles, General | Register to comment
Paul Dixey and Sam Walmsley offer some points to consider when developing an app.
The Mersey Burns app has just been launched on the iTunes Store and this and it is the first in the UK to be registered with the MHRA as a…
Read the full articlePharma gets social: five keys to effective corporate blogging – Lessons from JNJBTW
Posted 16th January 2012 in Articles, General | Register to comment
Daniel Ghinn continues his series reviewing social media activity in pharma with a look at J&J’s corporate blog – JNJBTW.
JNJBTW, Johnson & Johnson’s corporate blog, was one of the company’s early exploits into social media when it launched in 2007 and is …
Read the full articleTunnah’s musings: pharma deals with the January pipeline blues
Posted 13th January 2012 in Articles, General | Register to comment
As 2012 gets under way it looks like big pharma has an appetite for spending money, but is buying up all the biotechs really going to deliver the innovation the industry needs?
Whilst most of us are tightening our belts after another festive season, it seems like big pharma is in the mood for even more shopping in January…
Read the full articlePhysician perspectives: Mike Sevilla
Posted 12th January 2012 in Articles, General, Interviews | Register to comment
Kicking off our new physician series, family physician Mike Sevilla who acts as a social media ambassador to the Family Medicine Physician community shares his thoughts on how beneficial social media is to him and how other physicians can become engaged.
Mike Sevilla, a family physician, was formerly known as doctor anonymous and currently blogs at the site ‘Family medicine rocks’. Through his blogs…
Read the full articlePharma vs. physician: how data can relieve the headache (part 1)
Posted 11th January 2012 in Articles, General | 1 comment
In part one of a two-part article Kabir Shahani teaches how the right data can be used to gain a better insight into your target audience and achieve a competitive advantage.
As a founder of a healthcare software company, I hear leaders across the healthcare industry – from creative services companies to pharma executives…
Read the full article